Results 31 to 40 of about 526 (127)

Characteristics and Outcomes of Antivascular Endothelial Growth Factor Therapy in a Large Cohort of Patients With Pachychoroid Neovasculopathy [PDF]

Journal of Vitreoretinal Diseases
Amit Mishra, Parampal Grewal, Graeme Kenneth Loh   +2 more
exaly   +2 more sources

Active concurrent central serous chorioretinopathy and pachychoroid neovasculopathy managed with combination therapy of photodynamic therapy and anti-vascular endothelial growth factor agent

Indian Journal of Ophthalmology. Case Reports, 2021
Pachychoroid disease spectrum includes central serous chorioretinopathy (CSR) and pachychoroid neovasculopathy (PNV). Pachychoroid phenotype is characterized by choroidal hyperpermeability, dilated choroidal vessels (pachyvessels), and focal or diffuse ...
Barun Garg, Isha Gupta, Sugandha Goel, Deepak Senger, Kumar Saurabh, Rupak Roy   +5 more
doaj   +1 more source

Visualization of Type-1 Macular Neovascularization Secondary to Pachychoroid Spectrum Diseases: A Comparative Study for Sensitivity and Specificity of Indocyanine Green Angiography and Optical Coherence Tomography Angiography

Diagnostics, 2022
Background: The aim of this study was to compare optical coherence tomography angiography (OCTA) and indocyanine green angiography (ICGA) in detecting type-1 macular neovascularization (MNV) in pachychoroid spectrum diseases.
Sibel Demirel, Pınar Güran Beğar, Özge Yanık, Figen Batıoğlu, Emin Özmert   +4 more
doaj   +1 more source

Pachychoroid Spectrum Disorders: An Updated Review

Journal of Ophthalmic & Vision Research, 2023
Pachychoroid disease spectrum is a recent term that has been associated with an increasing number of phenotypes. This review discusses updated findings for each of the typical pachychoroid entities (central serous chorioretinopathy, pachychoroid pigment ...
Richard B. Brown, Sashwanthi Mohan, Jay Chhablani   +2 more
doaj   +1 more source

Anatomical and Functional Outcomes of Anti-VEGF Therapy in Pachychoroid Neovasculopathy. [PDF]

Clin Ophthalmol
Evaluation of real-life effectiveness of anti-VEGF therapy in patients diagnosed with pachychoroid neovasculopathy (PNV).This retrospective analysis included central serous chorioretinopathy (CSC) patients who developed PNV and underwent anti-VEGF treatment. Individuals with concomitant retinal diseases were excluded.
Sitnilska V, Pohl JM, Tang Y, Löw K, Lammert JQ, Krohne TU, Altay L.   +6 more
europepmc   +5 more sources

Central serous chorioretinopathy: A review

Clinical &Experimental Ophthalmology, Volume 51, Issue 3, Page 243-270, April 2023., 2023
Abstract Central serous chorioretinopathy (CSC) is the fourth most common non‐surgical retinopathy associated with fluid leakage. The pathogenesis is not yet completely understood, but changes in the choroid, sclera and RPE have been described associated with venous congestion of choroidal outflow.
Adrian T. Fung, Yi Yang, Andrew W. Kam
wiley   +1 more source

Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities

Acta Ophthalmologica, Volume 100, Issue 8, Page 946-959, December 2022., 2022
Abstract The pachychoroid disease spectrum (PDS) includes several chorioretinal diseases that share specific choroidal abnormalities. Although their pathophysiological basis is poorly understood, diseases that are part of the PDS have been hypothesized to be the result of venous congestion.
Joost Brinks, Elon H. C. van Dijk, Onno C. Meijer, Reinier O. Schlingemann, Camiel J. F. Boon   +4 more
wiley   +1 more source

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy. [PDF]

Sci Rep, 2019
AbstractThis retrospective study was to compare the efficacy of intravitreal injection of ranibizumab and aflibercept for patients with pachychoroid neovasculopathy. 54 eyes were initially treated with 3 monthly loading injections of ranibizumab or aflibercept. Treatment switching from ranibizumab to aflibercept, and aflibercept to photodynamic therapy
Jung BJ, Kim JY, Lee JH, Baek J, Lee K, Lee WK.   +5 more
europepmc   +4 more sources

Pachychoroid Spectrum Disorder Findings in Patients with Coronavirus Disease 2019

Case Reports in Ophthalmological Medicine, Volume 2021, Issue 1, 2021., 2021
Purpose. To report the occurrence of acute, bilateral, central serous chorioretinopathy (CSC), and pachychoroid spectrum disorder findings in patients with coronavirus disease 2019 (COVID‐19). Methods. In recovered cases of COVID‐19 with visual disturbances, complete ocular examinations with multimodal retinal and choroidal evaluation, including ...
Mojtaba Abrishami, Ramin Daneshvar, Nasser Shoeibi, Neda Saeedian, Hamid Reza Heidarzadeh, Seyedeh Maryam Hosseini, Stephen G. Schwartz   +6 more
wiley   +1 more source

Natural Course of Pachychoroid Pigment Epitheliopathy

Ophthalmology Science, 2022
Purpose: To investigate the natural course of pachychoroid pigment epitheliopathy (PPE). Design: A retrospective cohort study. Subjects: From the Kyoto central serous chorioretinopathy (CSC) cohort consisting of 548 patients with CSC as of September 2020,
Mariko Yagi, MD, Masahiro Miyake, MD, PhD, Yuki Mori, MD, Yoshikatsu Hosoda, MD, PhD, Ayako Takahashi, MD, PhD, Yuki Muraoka, MD, PhD, Naoko Ueda-Arakawa, MD, PhD, Manabu Miyata, MD, PhD, Kenji Yamashiro, MD, PhD, Hiroshi Tamura, MD, PhD, Sotaro Ooto, MD, PhD, Akitaka Tsujikawa, MD, PhD   +11 more
doaj   +1 more source